HIV Diagnosis Market Report 2024 (Global Edition)

Global HIV Diagnosis Market Report 2024 Market Size Split by Product (Consumables, Assays and Kits & Reagents, Other Consumables, Instruments, Software & Services), by Test Type (Antibody Tests, HIV-1...

HIV Diagnosis Market Report Description

We have various report editions of HIV Diagnosis Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the HIV Diagnostics Market

The market for HIV diagnostics is anticipated to continue changing as a result of technological developments, rising consumer demand for quick and precise testing options, and initiatives to provide diagnostic access in underserved areas. In the highly competitive world of HIV diagnostics, sustainable growth and innovation will depend on stakeholder collaboration and regulatory change adaptability.

February 2023: Roche announced that it is extending its partnership with the U.S. Centers for Disease Control and Prevention (CDC) to improve laboratory capacities in nations that are heavily impacted by the TB and HIV epidemics. Roche and the CDC will work to improve HIV and tuberculosis prevention, detection, and treatment outcomes in a few countries in Africa, Eastern Europe, Central Asia, and the Western Hemisphere (e.g., Latin America, Central America, and Caribbean regions) through the implementation of a public-private partnership (PPP) called "Lab Networks for Health”. Source: https://diagnostics.roche.com/us/en/news-listing/2023/roche-joins-cdc-strengthen-labs-fight-against-hiv-tuberculosis.html.

Top Companies Market Share in HIV Diagnosis Industry: (In no particular order of Rank)

• Bristol-Myers Squibb Company
• Abbott
• Alere Inc.
• Gilead Sciences
• Inc.
• Janssen Global Services
• LLC
• VIIV Healthcare
• Merck & Co. Inc.
• BD
• Beckman Coulter
• Inc.
• Sysmex Europe SE
• Apogee Flow Systems
• Point Care
• Zyomtronix
• Inc.
• Hoffmann-La Roche Ltd.
• Mylan N.V. F.
• Siemens Healthcare GmbH
• QIAGEN
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the HIV Diagnostics Market

Which Region Dominates the HIV Diagnostics Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. North America's strong healthcare infrastructure and high healthcare spending translate into a sizable portion of the worldwide HIV diagnostics market. In addition, the market is propelled by ongoing technology developments, rising HIV/AIDS prevalence, and robust government programs for HIV treatment and prevention. Furthermore, the presence of major players in the region especially in the US is expected to drive the growth of the market.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the HIV Diagnostics market. The epidemiological profiles of the region vary, with certain countries facing concentrated epidemics among critical populations such as injectable drug users, sex workers, and men who have sex with men (MSM). Testing and treatment initiatives are also driven by national HIV/AIDS control programs and initiatives that are funded by international organizations such as UNAIDS and WHO. Furthermore, the increasing awareness among the population is another important factor driving the market expansion in the region.

The current report Scope analyzes HIV Diagnosis Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America HIV Diagnosis

According to Cognitive Market Research, the global HIV Diagnostics market size was estimated at USD 4158.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1663.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the HIV Diagnostics market with a market size of USD 1312.33 million in 2024 and is projected to grow at a CAGR of 8.9% during the forecast period. The demand is amplified by the nation's rising HIV prevalence.
• The Canada HIV Diagnostics market had a market share of USD 199.59 million in 2024 and is projected to grow at a CAGR of 9.9% during the forecast period. Canada's growing investment.
• The Mexico HIV Diagnostics market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 151.36 million in 2024.

Europe HIV Diagnosis

According to Cognitive Market Research, the global HIV Diagnostics market size was estimated at USD 4158.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 1247.46 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031.

• The United Kingdom HIV Diagnostics market had a market share of USD 209.57 million in 2024 and is projected to grow at a CAGR of 10.2% during the forecast period. In the UK, High Strength RTD Malt beverage sales witness an upswing due to the growing prevalence of HIV.
• The France HIV Diagnostics market is projected to witness growth at a CAGR of 8.6% during the forecast period, with a market size of USD 114.77 million in 2024.
• According to Cognitive Market Research, the Germany HIV Diagnostics market size was valued at USD 247.00 million in 2024 and is projected to grow at a CAGR of 9.6% during the forecast period. In Germany, HIV Diagnostics sales surged due to the increasing investment.
• The Italy HIV Diagnostics market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 107.28 million in 2024.
• The Russia HIV Diagnostics market is projected to witness growth at a CAGR of 8.4% during the forecast period, with a market size of USD 193.36 million in 2024.
• The Spain HIV Diagnostics market is projected to witness growth at a CAGR of 8.5% during the forecast period with a market size of USD 102.29 million in 2024
• The Luxembourg HIV Diagnostics market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 38.67 million in 2024.
• The Portugal HIV Diagnostics market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 26.20 million in 2024.
• The Greece HIV Diagnostics market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 14.97 million in 2024.
• Rest of Europe's HIV Diagnostics market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 193.36 million in 2024.

Asia Pacific HIV Diagnosis

According to Cognitive Market Research, the global HIV Diagnostics market size was estimated at USD 4158.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 956.39 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.9% from 2024 to 2031.

• According to Cognitive Market Research, the China HIV Diagnostics market size was valued at USD 430.37 million in 2024 and is projected to grow at a CAGR of 12.4% during the forecast period. HIV Diagnostics sales surged in China due to increasing product launches.
• The Japan HIV Diagnostics market is projected to witness growth at a CAGR of 11.4% during the forecast period, with a market size of USD 131.98 million in 2024.
• The India HIV Diagnostics market had a market share of USD 114.77 million in 2024 and is projected to grow at a CAGR of 14.7% during the forecast period. India's growing healthcare expenditure.
• The South Korea HIV Diagnostics market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 95.64 million in 2024.
• The Australia HIV Diagnostics market is projected to witness growth at a CAGR of 12.6% during the forecast period, with a market size of USD 49.73 million in 2024.
• The South East Asia HIV Diagnostics market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 65.99 million in 2024.
• The Rest of the Asia Pacific HIV Diagnostics market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 67.90 million in 2024.

South America HIV Diagnosis

According to Cognitive Market Research, the global HIV Diagnostics market size was estimated at USD 4158.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 207.91 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil HIV Diagnostics market size was valued at USD 88.99 million in 2024 and is projected to grow at a CAGR of 10.9% during the forecast period. HIV Diagnostics sales flourish in Brazil due to the rising prevalence of sexually transmitted diseases.
• Argentina HIV Diagnostics market had a market share of USD 34.93 million in 2024 and is projected to grow at a CAGR of 11.2% during the forecast period. The growing investment drives the market growth in the nation.
• Colombia HIV Diagnostics market is projected to witness growth at a CAGR of 10.1% during the forecast period with a market size of USD 18.50 million in 2024.
• Peru HIV Diagnostics market is projected to witness growth at a CAGR of 10.5% during the forecast period with a market size of USD 17.05 million in 2024.
• Chile HIV Diagnostics market is projected to witness growth at a CAGR of 10.6% during the forecast period with a market size of USD 14.97 million in 2024.
• The Rest of Latin America HIV Diagnostics market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 33.47 million in 2024.

Middle East and Africa HIV Diagnosis

According to Cognitive Market Research, the global HIV Diagnostics market size was estimated at USD 4158.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 83.16 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031.

• The GCC Countries HIV Diagnostics market is projected to witness growth at a CAGR of 11.4% during the forecast period with a market size of USD 35.59 million in 2024. HIV Diagnostics sales flourish due to the growing investment in the healthcare sector.
• The Egypt HIV Diagnostics market is projected to witness growth at a CAGR of 10.9% during the forecast period, with a market size of USD 8.73 million in 2024.
• The South Africa HIV Diagnostics market is projected to witness growth at a CAGR of 11.6% during the forecast period, with a market size of USD 13.14 million in 2024. HIV Diagnostics sales flourish in South Africa due to the rising investment.
• The Turkey HIV Diagnostics market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 7.15 million in 2024.
• The Nigeria HIV Diagnostics market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 8.73 million in 2024.
• The Rest of MEA HIV Diagnostics market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 9.81 million in 2024.

HIV Diagnosis Market Analysis

HIV Diagnostics Market Product Segment Analysis

According to Cognitive Market Research, Consumables stand out as the dominating category. Due to rising diagnostic service demand, technology developments, and growing healthcare infrastructure, the market for consumables is expected to grow at a strong rate. Crucial supplies for this market include fixatives, processing chemicals, embedding mediums, staining reagents, and mounting media. The industry is expected to grow significantly in several areas, especially emerging countries, because of the increased frequency of sexually transmitted diseases and the adoption of cutting-edge technologies.

Software & Services emerge as the fastest-growing category in the HIV Diagnostics market due to improvements in technology and growing public awareness of HIV and AIDS. This increase can also be attributed to numerous government initiatives aimed at raising awareness and lessening the stigma associated with these illnesses. For example, the Centers for Disease Control and Prevention's Let's Stop HIV Together (Together) campaign aims to decrease stigma around HIV, increase diagnostics and testing, and boost knowledge of the virus.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of HIV Diagnosis Industry. Request a Free Sample PDF!

HIV Diagnostics Market Test Type Segment Analysis

According to Cognitive Market Research, the dominating category is Antibody Tests. Rapid testing and antibody-based assays, such as ELISA (Enzyme-Linked Immunosorbent Assay), are commonly utilized for HIV infection screening and early detection. They identify antibodies that are unique to HIV that the immune system produces in reaction to the infection. The accuracy of antibody tests has also been improved by ongoing advancements in assay sensitivity and specificity, which have decreased false positives and false negatives. The advent of fourth-generation tests that identify the p24 antigen in addition to HIV antibodies has increased early detection rates and fueled market expansion.

The fastest-growing category in the HIV Diagnostics market is CD4 Tests. In managing and treating HIV/AIDS, CD4 testing is essential, especially when it comes to tracking the disease's course and directing treatment choices. One important biomarker for evaluating the immunological health of people living with HIV is the CD4 T-cell count. Tracking CD4 levels aids in identifying the HIV infection stage, forecasts the course of the illness, and directs the start and continuation of antiretroviral medication (ART).

The above Graph is for representation purposes only. This chart does not depict actual Market share.

HIV Diagnosis Mode Segment Analysis

Mode Segment Analysis

According to Cognitive Market Research, the dominating category is Lab based. Because their results are accurate. Advanced equipment is used by skilled personnel in diagnostic laboratories or healthcare facilities to perform lab-based testing. It provides precise results, permits extended monitoring, and is necessary for intricate analysis and confirmatory tests. Technologies enabling rapid and point-of-care testing also shorten the interval between testing and the initiation of treatment, allowing for early intervention. The market has tremendous potential to improve efficiency, accuracy, and accessibility, which will eventually benefit HIV patients and the worldwide effort to combat the illness.

The fastest-growing category in the HIV Diagnostics market is Self test. Because they are convenient and easy to use. Self-testing enables anyone to use a self-collection kit to conduct diagnostic tests at home and interpret the data on their own. It makes early detection easier and provides anonymity. Self-test kits are now more widely available, more accurate, and offer quicker turnaround times. People can now take charge of their health and overcome obstacles like stigma and inconvenience associated with traditional testing methods. HIV diagnosis is facilitated by self-testing and lab-based testing methods that accommodate varying requirements and preferences, raise awareness, and allow for efficient viral control.

• Self test
• Lab based

HIV Diagnosis End User Segment Analysis

End User Segment Analysis

According to Cognitive Market Research, the dominating category is Diagnostic Laboratories. Numerous HIV tests, such as antibody/antigen assays, nucleic acid tests (NATs), CD4 counts, and viral load testing, are available from diagnostic labs. These labs have state-of-the-art equipment that allows for high-throughput testing, guaranteeing speedy and accurate findings.

The fastest-growing category in the HIV Diagnostics market is Hospitals. The affordability and accessibility of hospital-based treatments can be impacted by the price of sophisticated diagnostic tests and the intricacy of payment regulations. Maintaining hospital diagnostic services requires acceptable reimbursement rules and sufficient resources.

• Diagnostic Laboratories
• Hospitals
• Blood Banks
• Home Care Settings
• Other End Users

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion